Glaucoma is a second major cause of blindness in the United States. A major risk factor 55 for primary open angle glaucoma (POAG) is elevated intraocular pressure (IOP) caused by 56 increased resistance to aqueous humor outflow localized within the trabecular pathway (15, 56) . 57 Abnormal accumulation of extracellular matrix/material, which increases resistance to drainage 58 of aqueous humor through the trabecular pathway, is believed to be partly responsible for the 59 elevated IOP and POAG (24, 28, 49) . The cellular mechanisms that regulate the production and 60 turnover of extracellular matrix (ECM) within the outflow pathway, and how ECM turnover is 61 linked to regulation of aqueous humor outflow through the TM, are far from clearly understood 62 (13, 24, 27, 49) . Therefore, it would seem both necessary and critical to understand the molecular 63 basis of resistance to aqueous humor outflow. This knowledge may provide important insights 64 into the etiology of glaucoma and support development of effective therapies. Rho kinase, and from both, in vitro and in vivo model systems (11, 19, 41, 51) . These studies 73 suggest that agents which increase actin depolymerization, and decrease cell-ECM interactions 74 and myosin II phosphorylation within the cells of trabecular pathway, increase aqueous humor 75 outflow presumably by causing cellular relaxation, and by altering the geometry and stiffness of 76 the outflow pathway tissues, and fluid flow through the inner wall of SC (41, 51 (4, 20, 42, 53, 65) . TM cells exhibit smooth muscle-like physiology based on their 90 electromechanical properties (58) and the expression profile of various smooth muscle specific 91 proteins, including α-smooth muscle actin (αSMA) and 39, 51, 58 Fig 1A) . This change in cell morphology was associated with a robust increase in actin stress 244 fibers (phalloidin staining) and focal adhesion formation (vinculin staining) in RhoAV14 245 expressing TM cells (Fig.1B) . Additionally, immunoblot analysis of the membrane rich fraction 246 of the RhoAV14 expressing TM cells showed significantly increased levels of vinculin compared 247 to GFP expressing cells (Fig. 1C) . Similarly, analysis of myosin light chain (MLC) 248 phosphorylation in the RhoAV14 expressing H TM cells showed a marked increase compared to 249 control cells (Fig. 1D) . Moreover, quantitative immunoblot analysis of cell lysates derived from 250 the RhoAV14 expressing TM cells showed significantly increased levels of fibronectin, laminin,
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Tenascin C, and αSMA proteins compared to control cells expressing GFP alone (Fig. 1E) . The 252 RhoAV14 expressing TM cells also revealed increased filamentous and bundled organization 253 (fibrils) of the fibronectin compared to the untreated control cells (Fig. 1F) . ECM organization, we also evaluated the effects of TGF-β2 and LPA on these cellular events.
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The reason for choosing these two physiological agonists was that these agents have been shown 260 to increase the resistance to aqueous humor outflow in perfusion models (16, 33), and they 261 activate Rho/Rho kinase signaling in various cell types including TM cells (37, 39). Serum 262 starved HTM cells treated with LPA (5 μg/ml) and TGF-β2 (10 ng/ml) for two hours exhibited 263 increased actin stress fibers and focal adhesion formations ( Fig. 2A) . Further, similar to the 264 RhoAV14, these changes were associated with increased MLC phosphorylation and increased 265 levels of vinculin in the membrane-enriched fraction ( Fig.2B and C) . Moreover, both LPA and 266 TGF-β2 treated TM cells also revealed increased levels of fibronectin, laminin, and αSMA 267 compared to untreated control cells (Fig.2D) . Again as in the case of RhoAV14 expressing cells, 268 TGF-β2 and LPA treated HTM cells exhibited increased and compact assembly of fibronectin 269 compared to untreated control cells (Fig.2E) . Moreover, pretreatment of HTM cells with Rho 270 GTPase inhibitor (C3 transferase; 1.0μg/ml) for six hours suppressed the TGF-β2 and LPA 271 induced increases in the levels of fibronectin, laminin, and αSMA, (Fig. 3A) in association with 272 decreased actin stress fibers and focal adhesions (Fig. 3B) Fig. 5A and B) . On the other hand, both p38 MAPK and JNK did not 291 reveal any changes in phosphorylation status under similar conditions (data on JNK not shown).
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The protein levels of total Erk1/2 did not change in response to any of the above described 293 treatments ( Fig. 5A-C) . Further, the levels of phospho-Erk1/2 were found to be markedly 
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Wild type HTM cells treated for four hours with U0126, a highly selective inhibitor of 300 Erk1/2 (12), exhibited marked decreases in phospho-Erk 1/2 levels (Fig. 6A) . Importantly, 301 16 treatment with U0126 also resulted in significant reduction in the levels of both fibronectin and 302 αSMA proteins in wild type HTM cells compared to untreated controls (Fig. 6A) . Further, the 303 inhibition of fibronectin or αSMA expression by Erk inhibitor was not rescued by LPA, TGF-β2 304 or RhoAV14 (Fig. 6A and B) . On the other hand, a selective inhibitor of p38 MAPK (SB220025) 305 showed no effects on the expression of fibronectin or αSMA (Fig. 6B) in normal HTM cells. 306 Interestingly, the U0126 induced changes in fibronectin and αSMA expression were also 307 associated with decreases in MLC phosphorylation (Fig. 6C ) and in actin stress fibers (not to GFP expressing controls (Fig 7A) . Similarly, serum starved wild type HTM cells treated with 322 TGF-β2 for two hours revealed significant increases in SRF expression (Fig. 7A) . appears not to be dependent on SRF expression (Fig. 8B) . Interestingly, inhibition of Erk 349 activation in HTM cells decreased SRF protein levels, an effect that was not rescued by TGF-β2 350 indicating a requirement for Erk activity in the TGF-β2-induced expression of SRF (Fig. 8C) . (Fig. 9A & B) . Contrarily, shSRF expressing cells plated on fibronectin-coated plates 361 showed little changes in levels of αSMA, SRF, and phospho-Erk levels (Fig. 9A &B) . Further, 362 suppression of SRF expression in control TM cells reduced the basal levels of αSMA and 363 phospho-Erk (Fig. 9A & B) . 
